116 related articles for article (PubMed ID: 17613693)
1. Protein S100 as prognostic marker for gastrointestinal stromal tumors: a clinicopathological risk factor analysis.
Perez D; Demartines N; Meier K; Clavien PA; Jungbluth A; Jaeger D
J Invest Surg; 2007; 20(3):181-6. PubMed ID: 17613693
[TBL] [Abstract][Full Text] [Related]
2. [Gastrointestinal stromal tumor: a clinicopathological study of 74 cases].
Yang QC; Ji XH; Shen Y; Han F; Zhang XJ; Liu HB
Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):6-10. PubMed ID: 15796874
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal stromal tumor (GIST) in southern Taiwan: a clinicopathologic study of 93 resected cases.
Li CF; Chuang SS; Lu CL; Lin CN
Pathol Res Pract; 2005; 201(1):1-9. PubMed ID: 15807305
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
Can B; Sökmensüer C
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients.
Fujimoto Y; Nakanishi Y; Yoshimura K; Shimoda T
Gastric Cancer; 2003; 6(1):39-48. PubMed ID: 12673425
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal stromal tumors: a clinicopathologic and immunohistochemical study of 136 cases.
Orosz Z; Tornóczky T; Sápi Z
Pathol Oncol Res; 2005; 11(1):11-21. PubMed ID: 15800677
[TBL] [Abstract][Full Text] [Related]
7. The outcome of gastrointestinal stromal tumors (GISTs) after a surgical resection in our institute.
Tsukuda K; Hirai R; Miyake T; Takagi S; Ikeda E; Kunitomo T; Tsuji H
Surg Today; 2007; 37(11):953-7. PubMed ID: 17952524
[TBL] [Abstract][Full Text] [Related]
8. Study on Clinicopathological Features of Gastrointestinal Stromal Tumor and Relevant Prognostic Factors.
Liu Q; Wang Y; Kong L; Kan Y
Cell Biochem Biophys; 2015 Dec; 73(3):743-7. PubMed ID: 27259319
[TBL] [Abstract][Full Text] [Related]
9. A clinical and immunohistochemical study of gastrointestinal stromal tumours.
Khoo JJ; Gunn A
Malays J Pathol; 2005 Jun; 27(1):9-16. PubMed ID: 16676687
[TBL] [Abstract][Full Text] [Related]
10. [Expression of CD117, CD34, SMA, S-100 protein, Vim and desmin in patients with gastrointestinal stromal tumors].
Liu J; Liu YH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):438-40. PubMed ID: 18359707
[TBL] [Abstract][Full Text] [Related]
11. Synchronous gastrointestinal stromal tumors (GIST) and other primary cancers: case series of a single institution experience.
Ferreira SS; Werutsky G; Toneto MG; Alves JM; Piantá CD; Breunig RC; Brondani da Rocha A; Grivicich I; Garicochea B
Int J Surg; 2010; 8(4):314-7. PubMed ID: 20380900
[TBL] [Abstract][Full Text] [Related]
12. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics and prognosis of primary appendiceal stromal tumors.
Zhang B; Zheng GL; Zhu HT; Zhao Y; Zheng ZC
World J Surg Oncol; 2018 Nov; 16(1):225. PubMed ID: 30445975
[TBL] [Abstract][Full Text] [Related]
14. Prognostic analysis of rectal stromal tumors by reference of National Institutes of Health risk categories and immunohistochemical studies.
Tsai MC; Lin JW; Lin SE; Chen HH; Lee CM; Hu TH
Dis Colon Rectum; 2008 Oct; 51(10):1535-43. PubMed ID: 18633679
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of promyelocytic leukemia expression in gastrointestinal stromal tumor; integrated proteomic and transcriptomic analysis.
Ichikawa H; Yoshida A; Kanda T; Kosugi S; Ishikawa T; Hanyu T; Taguchi T; Sakumoto M; Katai H; Kawai A; Wakai T; Kondo T
Cancer Sci; 2015 Jan; 106(1):115-24. PubMed ID: 25457157
[TBL] [Abstract][Full Text] [Related]
16. Canine gastrointestinal stromal tumors: immunohistochemical expression of CD34 and examination of prognostic indicators including proliferation markers Ki67 and AgNOR.
Gillespie V; Baer K; Farrelly J; Craft D; Luong R
Vet Pathol; 2011 Jan; 48(1):283-91. PubMed ID: 20826846
[TBL] [Abstract][Full Text] [Related]
17. [Gastrointestinal stromal tumors: clinical, pathologic features and effectiveness of new diagnostic criteria].
Kim MK; Lee JK; Park ET; Lee SH; Seol SY; Chung JM; Kang MS; Yoon HK
Korean J Gastroenterol; 2004 Jun; 43(6):341-8. PubMed ID: 15220551
[TBL] [Abstract][Full Text] [Related]
18. Low ETV1 mRNA expression is associated with recurrence in gastrointestinal stromal tumors.
Sakamaki K; Funasaka K; Miyahara R; Furukawa K; Yamamura T; Ohno E; Nakamura M; Kawashima H; Hirooka Y; Fujishiro M; Goto H
Sci Rep; 2020 Sep; 10(1):14767. PubMed ID: 32901065
[TBL] [Abstract][Full Text] [Related]
19. Colorectal mesenchymal tumors - from smooth muscle tumors to stromal tumors.
Tai WC; Chuah SK; Lin JW; Chen HH; Huang HY; Kuo CM; Yi LN; Lee CM; Changchien CS; Hu TH
Oncol Rep; 2008 Nov; 20(5):1157-64. PubMed ID: 18949416
[TBL] [Abstract][Full Text] [Related]
20. Clinical and prognostic significance of Raf kinase inhibitory protein expression in gastrointestinal stromal tumors.
Wang Y; Chen JJ; Wang XF; Wang Q
World J Gastroenterol; 2018 Jun; 24(23):2508-2517. PubMed ID: 29930472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]